A Phase 3, Randomized, Double-Arm, Open-Label, Controlled Trial of ASP-1929 PhotoimmunotherapyVersus Physician???s Choice Standard of Care for the Treatment of Locoregional, Recurrent Head andNeck Squamous Cell Carcinoma in Patients Who Have Failed or

Project: Research project

Description

A Phase 3, Randomized, Double-Arm, Open-Label, Controlled Trial of ASP-1929 Photoimmunotherapy Versus Physician???s Choice Standard of Care for the Treatment of Locoregional, Recurrent Head and Neck Squamous Cell Carcinoma in Patients Who Have Failed or
StatusActive
Effective start/end date11/1/1810/30/22

Funding

  • RAKUTEN ASPYRIAN, INC.

Fingerprint

Standard of Care
Squamous Cell Carcinoma
Arm
Head
Physicians
Therapeutics
Carcinoma, squamous cell of head and neck